Current Appointments & Affiliations
Assistant Professor of Medicine
·
2023 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2024 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Immune checkpoint blockade in locally advanced rectal cancer with deficient DNA mismatch repair: retrospective multicenter experience.
Journal Article ESMO Open · January 2026 BACKGROUND: Prospective, single-institution studies in deficient DNA mismatch repair (dMMR) locally advanced rectal cancer (LARC) have shown high rates of complete clinical response (cCR) to neoadjuvant immune checkpoint inhibitor (ICI) monotherapy. PATIEN ... Full text Link to item CiteImmune checkpoint blockade in locally advanced rectal cancer with deficient mismatch repair (dMMR): Retrospective multicenter experience.
Conference Journal of Clinical Oncology · June 2025 e15628Background: Total neoadjuvant therapy (TNT) with cytotoxic chemotherapy and chemoradiation followed by surgical resecti ... Full text CiteAdoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014.
Journal Article Cancer Med · July 2021 BACKGROUND: This study analyzes the pattern of use of single agent anticancer therapy (SAACT) in the treatment and survival of advanced hepatocellular carcinoma (aHCC) before and after sorafenib was FDA approved in 2007. METHODS: Adult patients diagnosed w ... Full text Link to item CiteRecent Grants
An Interventional Phase 3 Double Blind Randomized Study to Evaluate the Efficacy and Safety of PF-08634404 in Combination with Chemotherapy versus Bevacizumab in Combination with Chemotherapy in Treatment-Naive Participants with Metastatic Colorectal
Clinical TrialPrincipal Investigator · Awarded by Pfizer, Inc. · 2026 - 2031Optimizing Body Mass Index (BMI) with TCMCB07 in Patients with Newly Diagnosed Metastatic Colore
Clinical TrialPrincipal Investigator · Awarded by Endevica Bio · 2025 - 2030Effectiveness of T-DXd across HER2-positive solid tumors in patients who have received prior systemic treatment and have no satisfactory alternative treatment options: A hybrid observational study
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca UK Limited · 2025 - 2030View All Grants
Education
Maulana Azad Medical College (India) ·
2011
M.B.B.S.